These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17910813)

  • 1. Carvedilol increases ciclosporin bioavailability by inhibiting P-glycoprotein-mediated transport.
    Amioka K; Kuzuya T; Kushihara H; Ejiri M; Nitta A; Nabeshima T
    J Pharm Pharmacol; 2007 Oct; 59(10):1383-7. PubMed ID: 17910813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
    Bader FM; Hagan ME; Crompton JA; Gilbert EM
    J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of imatinib mesilate on the disposition kinetics of ciclosporin in rats.
    Kajita T; Higashi Y; Imamura M; Maida C; Fujii Y; Yamamoto I; Miyamoto E
    J Pharm Pharmacol; 2006 Jul; 58(7):997-1000. PubMed ID: 16805961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of myricetin on the bioavailability of carvedilol in rats.
    Lee W; Woo ER; Choi JS
    Pharm Biol; 2012 Apr; 50(4):516-22. PubMed ID: 22132944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cilostazol on the pharmacokinetics of carvedilol after oral and intravenous administration in rats.
    Lim TH; Cho YA; Choi DH
    J Physiol Pharmacol; 2015 Aug; 66(4):591-7. PubMed ID: 26348083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.
    Spahn-Langguth H; Baktir G; Radschuweit A; Okyar A; Terhaag B; Ader P; Hanafy A; Langguth P
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):16-24. PubMed ID: 9476144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats.
    Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
    Hypertens Res; 2013 Apr; 36(4):349-55. PubMed ID: 23364340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
    Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
    Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of cyclosporin A blood levels during carvedilol treatment in renal transplant patients.
    Kaijser M; Johnsson C; Zezina L; Backman U; Dimény E; Fellström B
    Clin Transplant; 1997 Dec; 11(6):577-81. PubMed ID: 9408688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein.
    Bachmakov I; Werner U; Endress B; Auge D; Fromm MF
    Fundam Clin Pharmacol; 2006 Jun; 20(3):273-82. PubMed ID: 16671962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein.
    Incecayir T; Ilbasmis-Tamer S; Tirnaksiz F; Degim T
    Pharmazie; 2016 Aug; 71(8):472-477. PubMed ID: 29442035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol increases the systemic bioavailability of oral digoxin.
    De Mey C; Brendel E; Enterling D
    Br J Clin Pharmacol; 1990 Apr; 29(4):486-90. PubMed ID: 1970265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.
    Kakumoto M; Sakaeda T; Takara K; Nakamura T; Kita T; Yagami T; Kobayashi H; Okamura N; Okumura K
    Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin.
    Pathak SM; Udupa N
    Biopharm Drug Dispos; 2010 Mar; 31(2-3):202-14. PubMed ID: 20238375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil.
    Gramatté T; Oertel R
    Clin Pharmacol Ther; 1999 Sep; 66(3):239-45. PubMed ID: 10511059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
    Liu XL; Tang J; Song J; He J; Xu P; Peng WX
    Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contractility enhancing effect of the calcium sensitiser levosimendan is not attenuated by carvedilol in healthy subjects.
    Lehtonen L; Sundberg S
    Eur J Clin Pharmacol; 2002 Oct; 58(7):449-52. PubMed ID: 12389066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
    Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
    Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.